Summary by Futu AI
HANSEN PHARMACEUTICAL GROUP LIMITED ANNOUNCES THAT A BOARD MEETING WILL BE HELD ON TUESDAY, MARCH 26, 2024. The primary purpose of the meeting is to consider and approve the annual results of the Company and its subsidiaries for the year ended 31 December 2023 and to discuss the proposed final dividend (if any). In addition, the meeting will deal with other matters. The members of the Board of Directors include Chairman and Executive Director Ms. Chung Wai Chuan, Executive Director Mr. Lu Aifeng and Ms. Sun Yuen; and Independent Non-Executive Directors Mr. Lin Guoqiang, Mr. Chan Shang Wei and Ms. Yang Tong Tao.